BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22530726)

  • 1. Short and long-term management of haemophilia A patient requiring heart valve surgery.
    Zatorska K; Orłowska-Baranowska E; Abramczuk E; Kuśmierczyk M; Greszata L; Grabowski M; Stępińska J; Baran B; Windyga J
    Haemophilia; 2012 Jul; 18(4):e352-4. PubMed ID: 22530726
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A.
    Stine KC; Becton DL
    Haemophilia; 2006 Jul; 12(4):435-6. PubMed ID: 16834747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How we manage prostate biopsy and prostate cancer therapy in men with haemophilia.
    Fogarty PF; Kouides P
    Haemophilia; 2012 May; 18(3):e88-90. PubMed ID: 22500858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced early prophylaxis of children with haemophilia in a developing country, Turkey.
    Celkan T; Ozdemir N
    Haemophilia; 2011 Sep; 17(5):e840-1. PubMed ID: 21682819
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary prophylaxis in an adult patient with severe haemophilia A. Factor VIII consumption and effectiveness.
    Schlenkrich S; Schubert C
    Hamostaseologie; 2013 Aug; 33(3):241-4. PubMed ID: 23435748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficult clinical challenges in haemophilia: international experiential perspectives.
    Forsyth AL; Giangrande P; Hay CR; Kenet G; Kessler CM; Knöbl PN; Llinás A; Santagostino E; Young G
    Haemophilia; 2012 Jul; 18 Suppl 5():39-45. PubMed ID: 22757683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
    Thornburg CD; Pipe SW
    Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
    [No Abstract]   [Full Text] [Related]  

  • 8. Considerations in individualizing prophylaxis in patients with haemophilia A.
    Valentino LA
    Haemophilia; 2014 Sep; 20(5):607-15. PubMed ID: 24712891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocytic receptor for pro-coagulant factor VIII: relevance to inhibitor formation.
    Navarrete AM; Dasgupta S; Teyssandier M; Repesse Y; Delignat S; André S; Bayry J; Kaveri SV; Lacroix-Desmazes S
    Thromb Haemost; 2010 Dec; 104(6):1093-8. PubMed ID: 20886186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing outcomes for patients with severe haemophilia A.
    Pipe SW; Valentino LA
    Haemophilia; 2007 Nov; 13 Suppl 4():1-16; quiz 3 p following 16. PubMed ID: 17822512
    [No Abstract]   [Full Text] [Related]  

  • 11. Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
    Brackmann HH; Gormsen J
    Haemophilia; 2010 May; 16(102):2-3. PubMed ID: 20536980
    [No Abstract]   [Full Text] [Related]  

  • 12. Simplified nonresectional leaflet remodeling mitral valve repair for degenerative mitral regurgitation.
    Woo YJ; MacArthur JW
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):749-53. PubMed ID: 21943963
    [No Abstract]   [Full Text] [Related]  

  • 13. Annulus-edge-papillary stitch to repair P2 of the mitral valve posterior leaflet.
    Kassem S; Othman M
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):e45-7. PubMed ID: 21420105
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice.
    Manco-Johnson M
    Haemophilia; 2007 Sep; 13 Suppl 2():4-9. PubMed ID: 17685917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting factor VIII for hemophilia A creates hope for less taxing treatment.
    Morrow T
    Manag Care; 2014 Jul; 23(7):46-7. PubMed ID: 25199371
    [No Abstract]   [Full Text] [Related]  

  • 16. Octocog alfa (Advate®): a guide to its use in hemophilia A.
    Keating GM; Dhillon S
    BioDrugs; 2012 Aug; 26(4):269-73. PubMed ID: 22759264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eComment: Continued postoperative left ventricle remodeling affects the initial good outcome of the restrictive mitral valve annuloplasty.
    Garcia-Villarreal OA
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):228. PubMed ID: 21257954
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of arthropathy in haemophilia: prophylaxis.
    Santagostino E; Mancuso ME
    Haemophilia; 2008 Nov; 14 Suppl 6():16-9. PubMed ID: 19134028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A.
    Richards M; Williams M; Chalmers E; Liesner R; Collins P; Vidler V; Hanley J;
    Br J Haematol; 2010 May; 149(4):498-507. PubMed ID: 20230411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of intracardiac hemodynamics in plasty of the mitral valve with a synthetic band, early period of observation].
    Shneĭder IuA; Talipov IR; Uzhakhov IR
    Vestn Khir Im I I Grek; 2011; 170(5):54-6. PubMed ID: 22238967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.